Thiazolopyrimidine kinase inhibitors

Details for Australian Patent Application No. 2006278627 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Johnson, Sigmond G.; Connolly, Peter J.; Moreno-Mazza, Sandra J.; Binnun, Eva; Middleton, Steven A.; Pandey, Niranjan B.; Wetter, Steven K.; Lin, Ronghui

Agent Shelston IP

Pub. Number AU-B-2006278627

PCT Pub. Number WO2007/019191

Priority 60/706,840 08.08.05 US

Filing date 2 August 2006

Wipo publication date 15 February 2007

Acceptance publication date 18 August 2011

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/33 (2006.01) - Heterocyclic compounds

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/019191 Priority application(s): WO2007/019191

18 August 2011 Application Accepted

  Published as AU-B-2006278627

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278639-Method and system for reporting a short message capability via an IP multimedia subsystem

2006278622-Method for treating skin irritations such as diaper rash and the like